Two anti-heparanase antibodies (multiple antigenic peptides MAP1-2) can effectively prevent the heparanase activity of hepatic cancer cells (HCCLM6), thereby affecting their invasive capability and indicating their pivotal role in HCC tumor growth and metastasis [18]. The gene discussed is HPSE; the disease is hepatocellular carcinoma.